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INTRODUCTION
The transforming growth factor β (TGF-β) superfamily of cytokines
is essential for the regulation of numerous biological processes.
Skeletal muscle growth is negatively regulated by several TGF-β
molecules, including activin A and myostatin, which signal through
the activin type I and type II serine/threonine kinase receptors (Link
and Nishi, 1997; Lee et al., 2005; Lee et al., 2012). Activation of
type II receptors by ligand binding causes hyperphosphorylation of
serine residues on the glycine/serine-rich domain of type I receptors
(Attisano et al., 1996), which subsequently propagates TGF-β signals
by activation of the SMAD signaling cascade (Attisano and Wrana,
2002). While the activin type II receptors (A and B) are utilized by
numerous TGF-β ligands, signaling specificity is maintained through
combinations of SMAD and type I receptor activation (Feng and
Derynck, 2005). The interaction between activin type II and type I
receptors occurs through the intracellular serine/threonine kinase
domains of each receptor and truncation of the type II kinase domain
has been shown to inhibit signaling (Tsuchida et al., 2008).
Overexpression of a truncated activin receptor IIB (ACVR2B) or
supplementation with a soluble receptor is now commonly used to
inhibit signaling through the dominant negative inhibition of
endogenous ACVR2B (Wang and McPherron, 2012; Lee et al.,
2012).
Myostatin, a ligand of the ACVR2B, is a key regulator of skeletal
muscle growth in mammals. Deletion or inhibition of myostatin,
through gene knockout (McPherron et al., 1997) or overexpression
of inhibitors (Lee and McPherron, 2001), markedly increases
muscle mass in mice. Similarly, ‘double-muscled’ phenotypes in
cattle and whippets result from natural myostatin mutations
(Kambadur et al., 1997; McPherron and Lee, 1997; Mosher et al.,
2007). Myostatin, however, is not the only ACVR2B ligand required
for regulating mammalian muscle growth. This is supported by the
fact that injection of a soluble form of the ACVR2B or
overexpression of follistatin, both of which inhibit several TGF-β
molecules, increases muscle mass in myostatin-null mice (Lee et
al., 2005; Lee, 2007). In addition to myostatin, activin A and GDF-
11 have a similar affinity for the extracellular domain of ACVR2B
(Sako et al., 2010) and have all been found to regulate myoblast
differentiation in vitro (Souza et al., 2008).
Currently, little is known about the mechanisms regulating
muscle growth in teleost fish, despite the fact that teleosts encompass
almost half of all known vertebrate species (Zou and Jiang, 2008).
The myostatin peptide sequence is highly conserved among fish
and terrestrial vertebrates (Pie and Alvares, 2006); however,
mammals possess a single form of myostatin found predominantly
in muscle tissue, whereas multiple forms are differentially expressed
throughout most of the tissues in teleost fish (Østbye et al., 2001;
Rescan et al., 2001; Garikipati et al., 2006). Two forms of the acvr2b
have recently been discovered in sea bream (Sparus aurata,
Linnaeus 1758), with several other teleost species being identified
as having multiple forms through bioinformatics resources
(Funkenstein et al., 2012). The presence of multiple genes is
common among teleost species because of a well-characterized
genome duplication that occurred early in teleost evolution with a
second gene duplication event occurring in the salmonid lineage.
Sea bream follistatin and the myostatin prodomain inhibit
myostatin in vitro, suggesting that teleost myostatin is regulated by
mechanisms similar to that of mammals (Rebhan and Funkenstein,
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2008). In vitro studies have also demonstrated that the extracellular
domain of sea bream Acvr2b-1 is capable of inhibiting myostatin
signaling (Funkenstein et al., 2012). Small increases in muscle mass
have been reported in homozygous transgenic zebrafish [Danio rerio
(Hamilton 1822)] by overexpression of the myostatin pro-domain
(Xu et al., 2003; Lee et al., 2009) and by myostatin RNAi (Lee et
al., 2009). Myostatin-deficient medaka [Oryzias latipes (Temminck
and Schlegel 1846)] also exhibit enhanced muscle growth (Chisada
et al., 2011). Zebrafish and medaka, however, exhibit determinate
growth and are restricted to minor increases in muscle mass (Biga
and Meyer, 2009). An increase in mass has been reported for fish
species capable of indeterminate growth (i.e. non-growth limited)
following injection or submersion in a bath of a soluble form of the
Acvr2b (Carpio et al., 2009) or myostatin pro-domain (Lee et al.,
2010a); however, this research was limited to only larval and early
juvenile life stages. In the research presented here, transgenic trout
overexpressing a truncated acvr2b-2a (acvr2b∆) were produced to
investigate the involvement of Acvr2b signaling in the long-term
regulation of muscle mass in a teleost species with indeterminate
growth.
MATERIALS AND METHODS
Cloning RBT acvr2b-2a
Total RNA was extracted from white muscle (fast twitch) tissue of
juvenile rainbow trout [RBT; Oncorhynchus mykiss (Walbaum
1792)] and adult zebrafish using Tri-Reagent (Molecular Research
Center, Cincinnati, OH, USA), and cDNA was synthesized using
oligo(dT)18 primers (New England Biolabs, Ipswich, MA, USA)
and Moloney murine leukemia virus reverse transcriptase (New
England Biolabs). The complete RBT acvr2b-2a coding sequence
(CDS) was amplified by PCR using degenerate primers (Integrated
DNA Technologies, Coralville, IA, USA) designed to conserved
regions of the zebrafish (GenBank accession no. AF069500) and
grass carp [Ctenopharyngodon idella (Valenciennes 1844),
FJ198047] acvr2b mRNA sequences (Table1).
DNA construct
A truncated acvr2b-2a construct [Tg(RA.Mlc:acvr2b∆)] was
prepared using a 528bp fragment of the 5′ end of the zebrafish
acvr2b-2a CDS, which included 31bp of the 5′ untranslated region,
the extracellular and transmembrane domains, and a residual 17bp
of the kinase domain. The zebrafish acvr2b-2a sequence was used
for production of transgenic RBT because of its detailed molecular
characterization (Garg et al., 1999) and conservation to RBT
acvr2b-2a (89% amino acid conservation of the extracellular
domain). Using the zebrafish acvr2b-2a sequence also enabled
differentiation from the native RBT receptor transcript for precise
quantification of transgene expression levels. The acvr2b∆ was
cloned into a skeletal muscle-specific expression vector containing
a rat myosin light chain (RA.Mlc) promoter and enhancer and an
SV40 polyadenylation sequence, generously provided by Dr Shao
Jun Du of the University of Maryland (Rosenthal et al., 1989; Xu
et al., 2003; Medeiros et al., 2009). This construct was separated
from the vector backbone by NotI (New England Biolabs) restriction
digestion and the linear construct was purified by electrophoresis
through a 1% agarose gel and quantified with a NanoDrop
spectrophotometer (Thermo Fisher Scientific, Newark, DE, USA).
The Tg(RA.Mlc:acvr2b∆) construct was sequenced in both directions
at the University of Rhode Island Genomics and Sequencing Center
(URI GSC) to verify sequence and insert orientation.
Microinjection
Rainbow trout ova (Arlee strain; Ennis National Fish Hatchery,
Ennis, MT, USA) were fertilized 30min to 3h prior to use and
maintained at 4°C in RBT isotonic saline (9.04gl−1 NaCl, 0.24gl−1
KCl, 0.34gl−1 CaCl2) to prevent hardening of the chorion and to
slow development. Ova were microinjected through the micropyle
with 1 million copies of linearized construct in a total volume of
18nl as previously described (Medeiros et al., 2009).
Husbandry
After microinjection, ova were transferred to flow through vertical
tray incubators (MariSource, Fife, WA, USA). Following yolk sac
absorption, trout were transferred to 0.27m3 tanks supplied with single
pass water ranging seasonally from 4 to 16°C and exposed to a
simulated natural photoperiod. The fish were maintained at low
densities and fed seven times daily with a commercially formulated
feed (Corey Feed Mills, Fredericton, NB, Canada). After screening
for the presence of the construct, a random sample of non-transgenic
(control) fish were marked by excision of the adipose fin and raised
communally with transgenic fish to eliminate environmental
variability (i.e. tank effect). All RBT were implanted with a passive
integrated transponder (PIT) tag (Biomark, Boise, ID, USA) and
transferred to 2m diameter (1.7m3 volume) flow through tanks once
they attained a mass of 15g. Juvenile trout were fed to satiation three
times daily with commercial trout feed (Silver Cup, Murray, UT,
USA) and adult RBT were provided a broodstock feed (Aquabrood;
Corey Feed Mills) 6months prior to sexual maturation to enhance
Table1. Primer sets used in the production, screening and qRT-PCR of acvr2b∆ transgenic trout and those used in discovery of the rainbow
trout (RBT) acvr2b-2a gene
Primer Orientation Sequence (5′–3′)
ZFacvr2b-F Fwd GCT CCT CCG GGT TTA TTT TC
ZFacvr2b-R Rev GAG GGC ACT CTA GGC TTG TG
Mylc 5 Fwd CAC CAC TGC TCT TCC AAG TGT CA
acvr2b R6 Rev TGT CCG GCA GGT GTG TAA ATC TCT
RBT acvr2b F1 Fwd ATT ARA GGA ATA TGT TCG CTT C
RBT acvr2b R342 Rev CGT TGA CAT CAG GCA GGT A
RBT acvr2b F93 Fwd GCA CTG CTA CGC CTC VTG G
RBT acvr2b R1141 Rev CCT CCT CAA ACG GCA GCA TGT AC
RBT acvr2b F970 Fwd TAA GAA TGT GAT GCT GCG GAC
RBT acvr2b R1604 Rev GTT CAG ATG CTG GAC TCT TTG G
qRT-PCR acvr2b F230 Fwd GCT GGC TCG ACG ACT TCA ACT
qRT-PCR acvr2b R4 Rev CAT AGG GTG GCT TGT GGT GGC G
qRT-PCR gapdh F Fwd ACC ACT ACA ACC CAA TCA ACA GCA A
qRT-PCR gapdh R Rev TCG ATG AAG GGA TCG TTG ATG GC
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ova quality. Fish that reached maturity at 2years of age were
manually spawned using established husbandry practices (Piper et
al., 1982) and the gametes from transgenic trout were used to produce
F1 families. F1 offspring were raised in conditions identical to those
of the parental generation (i.e. communal tanks and adipose fin clip
for non-transgenic fish) but were not PIT tagged for identification of
individuals. During handling and sampling, fish were anesthetized in
a solution of 0.075gl−1 tricaine methanesulfonate (Argent Chemical
Laboratories, Redmond, WA, USA) to reduce stress and facilitate
handling. All protocols involving animals were approved by the
University of Rhode Island Institutional Animal Care and Use
Committee (AN01-04-031 and AN08-02-012).
Transgenic screening
Juvenile RBT were screened for integration of the construct at a
body mass of ~2g using an established protocol (Medeiros et al.,
2009). Briefly, a small quantity of caudal fin was excised and assayed
by PCR with a vector-specific forward primer and an acvr2b∆-
specific reverse primer (Table1). Transgenic fish were identified
by the presence of an amplicon after electrophoresis of the PCR
products through a 1% agarose gel.
Gene expression
White muscle tissue was excised from P1 juveniles by a 4mm biopsy
(Premier Medical Products Company, Plymouth Meeting, PA,
USA) adjacent to the dorsal fin or by lethal sampling in the F1
generation. Residual skin was removed and 20–25mg of muscle
was flash frozen in a dry-ice–ethanol bath. The tissue was
homogenized with a 5mm stainless steel bead in a chaotropic
solution using a TissueLyser (Qiagen, Valencia, CA, USA) at 25Hz
for 5min. RNA was isolated from the tissue homogenates after
aqueous phase separation using 96-well RNeasy plates (Qiagen).
To eliminate the potential of DNA contamination, samples were
digested on the column with 80μl of DNase I (0.34Kunitzμl–1,
Qiagen) for 15min. Purified RNA was eluted in RNase-free
molecular grade water followed by short-term storage at −80°C.
Quantitative reverse transcription PCR (qRT-PCR) with SYBR
Green fluorescence (Brilliant SYBR Green qRT-PCR Master Mix,
1 step, Stratagene, La Jolla, CA, USA) was used to verify acvr2b∆
expression. The qRT-PCR reaction was conducted using 50ng of
purified total RNA under the following conditions: 50°C for 30min,
95°C for 10min, and 40 cycles of 95°C for 30s and 65°C for 1.5min.
A dissociation curve was generated to ensure a single amplicon was
produced, by denaturing each amplified sample at 95°C for 1min,
followed by 55°C for 30s, and increasing the temperature by 0.5°C
per 30s cycle for 80 cycles. All qRT-PCR samples were assayed
in triplicate alongside a duplicate six-point standard curve made from
purified PCR product. Triplicate samples lacking reverse
transcriptase enzyme or template were assayed to verify the absence
of DNA or reagent contamination. Glyceraldehyde 3-phosphate
dehydrogenase (gapdh) expression was also quantified for each
sample to normalize expression data. Analysis of gapdh samples
was performed with an annealing temperature of 63°C, in triplicate
with appropriate standard curve and control samples similar to the
acvr2b∆ qRT-PCR assay. All reactions were performed on a
MX4000 Real Time PCR system (Stratagene) and amplicons from
both qRT-PCR reactions and respective standard products were
sequenced at the URI GSC.
Growth and phenotypic characterization
The growth of each P1 transgenic and non-transgenic sibling
control fish was measured five times between 9 and 15months of
The Journal of Experimental Biology 216 (19)
age by obtaining a digital image and mass to the nearest 0.1g. Length
measurements were obtained from photographs using Image-Pro
Plus version 5.0.1 (MediaCybernetics, Bethesda, MD, USA) after
calibrating pixels per centimeter at two locations on the image.
Length was measured to the nearest 0.01cm from the tip of the
snout to the center, posterior edge of the caudal peduncle. The P1
generation was randomly divided into cohorts 1 (N=20 transgenic
fish) and 2 (N=10 transgenic fish) to maintain low densities. The
growth of each cohort was analyzed separately. Condition factor
and specific growth rate were calculated for each individual
transgenic and control fish. Condition factor, a ratio of fish mass
to length, was calculated using the formula (M/L3)×100, where M
is mass in grams and L is length in centimeters. Specific growth
rate is defined as the percent of body mass gained per day over a
defined period and is calculated by the formula: {[ln(final
mass)–ln(initial mass)]×100}/total days between measurements.
To examine the growth characteristics of the F1 generation, fork
length (cm) and mass (g) of acvr2b∆ trout were measured six times
between 5 and 10months of age. Nine transgenic fish from line
Tg(RA.Mlc:acvr2b∆)aa26-24 were raised in a 1.6m3 circular tank
with a random group of 19 non-transgenic siblings (controls). The
condition factor for F1 transgenic and control fish was calculated
at each growth inventory using length and mass measurements.
Muscle histology
Muscle histology was examined in Tg(RA.Mlc:acvr2b∆)aa26-24 F1
offspring at 4months post-hatch (6.6±0.4g, 7.4±1.4cm). Seven
transgenic and control fish were euthanized with an overdose of
tricanine methanesulfonate followed by measurement of mass and
length. Two 5×5mm cubes were excised from the epaxial section of
the ‘steak’ just anterior to the dorsal fin and oriented to allow for a
cross-sectional cut. Tissue was frozen in cryosectioning embedding
medium (Tissue tek, Thermo Fisher Scientific) for 20s in isopentane
chilled in a bath of liquid nitrogen. Muscle fiber number, diameter
and the area of cross-sectional muscle tissue were analyzed as
previously described (Medeiros et al., 2009). The total cross-sectional
muscle surface area and subsample muscle fiber number were used
to extrapolate the total fiber number per cross-section.
Data analysis
Statistical analyses were performed using SAS version 9.2 (SAS
Institute, Cary, NC, USA). Mass, length, condition factor and
specific growth rate of P1 acvr2b∆ transgenic and sibling control
fish were compared using a two-way ANOVA with repeated
measures on one factor after testing for sphericity. An independent
samples t-test, with or without the assumption of equal variances
between groups, was used to analyze F1 cross-sectional area, total
fiber number, muscle fiber diameter and unit fiber number, and for
the growth studies of the F1 generation. Pearson correlations were
calculated comparing acvr2b∆ expression levels with the mass and
length of P1 transgenic fish. Values are reported in the text as means
± s.e.m. Differences were considered significant at P<0.05.
RESULTS
Rainbow trout acvr2b-2a CDS
The full-length CDS of RBT acvr2b-2a (GenBank accession no.
HM143891) possessed a high degree of conservation with other teleost
acvr2b sequences including: Atlantic salmon (94%, Salmo salar,
Linnaeus 1758, EF063143.1), grass carp (83%, C. idella, FJ198047.1),
zebrafish (82%, D. rerio, NM_131210.2), gilthead sea bream (82%,
S. aurata, JF906099) and goldfish [80%, Carassius auratus (Linnaeus
1758), AF001406.1]. The mRNA sequences of chicken [Gallus gallus
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(Linnaeus 1758), NM_204317.1] and human (Homo sapiens,
Linnaeus 1758, BC099642.4) ACVR2B were 76% similar to RBT
acvr2b-2a. The deduced amino acid sequence of the extracellular
domain of RBT Acvr2b-2a was 89% identical to that of zebrafish
(Fig.1), and all 10 cysteine residues conserved in the extracellular
domain of other Acvr2b proteins (Garg et al., 1999) were present.
Rate of transgenesis and maturation
A total of 1581 fertilized eggs were microinjected with the
Tg(RA.Mlc:acvr2b∆) DNA construct. Of the 292 surviving juvenile
trout, 48 integrated the DNA construct (16.4%). Of these, only 18%
of the P1 transgenic females spawned at 2years of age, despite being
of sufficient size (2–4kg) to attain sexual maturation; 50% of control
females spawned. Examination of three moribund females post-
spawning season revealed developing reproductive tissue in two
individuals with no signs of oocyte development in the third. At
3years of age, the remaining control and acvr2b∆ females matured.
There was no difference in the time of maturation for control and
acvr2b∆ males. Mendelian inheritance was not observed in the
majority of acvr2b∆ × acvr2b∆ F1 families, suggesting that there
was substantial germline transgene mosaisicm in P1 founders.
acvr2b∆ expression
Absolute qRT-PCR analysis detected acvr2b∆ expression in the
muscle tissue of most P1 transgenic RBT, with expression varying
widely among individuals (0–7,657,000 transcripts). The majority
of transgenic fish (69%) produced in excess of 1,000,000 copies of
acvr2b∆ per 50ng of total RNA. No acvr2b∆ transcript was detected
in 12 fish that assayed negative for the presence of the construct in
gDNA. The expression of gapdh did not vary between transgenic
(19,943±1919 transcripts) and control (19,411±1038 transcripts)
fish. There was no correlation between the mass or length of P1
transgenics and acvr2b∆ transcript levels (mass R2=0.134, length
R2=0.163). The highest transcript levels were observed in two of
the smallest individuals, which exhibited an abnormally short,
compact body morphology (7,657,000 and 6,025,000 transcripts),
whereas the two largest fish had moderate levels of acvr2b∆
expression (2,015,000 and 1,507,000 transcripts). Transgene
expression was detected in all assayed F1 transgenic lines, with
expression ranging between 100,000 and 1,000,000 copies per 50ng
of RNA, depending on the line (data not shown).
Transgenic P1 phenotype
A phenotype characterized by enhanced muscling, with numerous
individuals having both well-defined hypaxial regions as well as
large masses of epaxial muscle, was observed in P1
Tg(RA.Mlc:acvr2b∆) transgenic fish (Fig.2A). In several individuals,
examination of the interior abdominal wall revealed protrusions of
muscle between the hemapophysial ribs corresponding to locations
of external ridges. The degree and location of muscling varied among
transgenic individuals, with some exhibiting muscle asymmetry
(Fig.2B). No additional morphological anomalies were observed in
RBT    M F AS C L T F AL L G - T FC A G P S HG E V D T QE C L F Y NI N Y E I E K T N Q S G V E R C E GE K D K R S H C Y 
ATS    - - -- - - - - -- - - - - -- - - - - -- - - - - RE C L F Y NV N Y E I E K T N Q S G V E R C E GE K D K R L H C Y 
GCP    M F AS W L T F AL L L G T FC A G P S HG E V E T RE C L Y F NI N W E I E K T N R S G V E R C E GE K D K R S H C Y 
ZBF    M F AS L L T L AL L L A T FA A D P S HG E V E T RE C L Y Y NV N W E V E K T N R S G V E R C E GE K D K R S H C Y 
  
RBT    A S WR N N S G TI E L V K KG C W L D DF N C Y D RQ E C V A TE E N P Q V F F C C C E G N F C N ER F T H L P D I N 
ATS    A S WR N N S G TI E L V K KG C W L D DF N C Y D RQ E C V A TE E N P Q V F F C C C E G N F C N ER F T H L P D V N 
GCP    A S WR N N S G SI E L V K KG C W L D DF N C Y D RQ E C V A TE E N P Q V F F C C C E G N F C N ER F T H L P D V S 
ZBF    A S WR N N S G SI Q L V K KG C W L D DF N C Y D RQ E C V A TE E N P Q V F F C C C E G N F C N ER F T H L P D I S 
  
RBT    G P LI K S P P PM P T L L NV L V Y S LL P I T M LS M A L L LA F W M Y R H H K P P Y G H V D I NE D P G L V P P P 
ATS    G P TI K P P P PM P T L L NV L V Y S LL P I T M LS M A L L LA F W M Y R H R K P P Y G H V D I NE D P G L V P P P 
GCP    G P VI E P P P PT P S L L NV L V Y S LL P I T M LS M A L L LA F W M Y R H R K P P Y G H V D I NE D P G P S P P - 
ZBF    G P VI S P P P VS P S L L NV L V Y S LL P L S M LS M A V L LA F W M Y R H R K P P Y G H V D V NE D P G P S P P - 
  
RBT    S P LV G L K P LQ L L E I KA R G R F GC V W K A QM M N D Y VA V K V F P I Q D K Q S W T N E R DV F L T P G M K H 
ATS    S P LV G L K P LQ L L E I KA R G R F GC V W K A QM M N E Y VA V K V F P I Q D K Q S W M N E R DV F L T P G M K H 
GCP    S P LV G L K P LQ L L E V KA R G R F GC V W K A QM M N E Y VA V K I F P I Q D K Q S W Q N E W DI F S T P G M K H 
ZBF    S P LV G L K P LQ L L E V KA R G R F GC V W K A QM I N E Y VA V K I F P I Q D K L S W Q N E R EM F S T P G M K H 
  
RBT    E N LL R Y I A AE K R G T NL E M E L WL I S E F HE R G S L TD Y L K G N A I S W T E L C H I A ET M A C G L A Y L 
ATS    E N LL R Y I A AE K R G T NL E M E L WL I S E F HQ R G C L TD Y L K G N A I S W T E L C H I S ET M A C G L A Y L 
GCP    D N LL R Y I A AE K R G S NL E T E F WL I T E F HE R G S L TD Y L K G N V V S W S D L C H I A ET M A C G L A Y L 
ZBF    D N LL R F I A AE K R G S NL E M E F WL I T E F HE R G S L TD Y L K G N A V S W A D L C V I A ES M A C G L A Y L 
  
RBT    H E DV P R Y K GE G P K P AI A H R D FK S K N V ML R T D L TA I I G D F G L A V R F E P G K P PG D T H G Q V G T 
ATS    H E DV P R Y K GE G P K P AI A H R D FK S K N V ML R T D L TA I I G D F G L A V R F E P G K P PG D T H G Q V G T 
GCP    H E DV P R F K GE G P K P AI A H R D FK S K N V ML K T D L TA V V G D F G L A V R F E P G K P PG D T H G Q V G T 
ZBF    H E DV P R S K GE G P K P AI A H R D FK S K N V ML K M D L TA V I G D F G L A V R F E P G K P PG D T H G Q V G T 
  
RBT    R R YM A P E V LE G A I N FQ R D A F LR I D M Y SM G L V L WE L V S R C K A A D G P V D E Y M LP F E E E I G Q H 
ATS    R R YM A P E V LE G A I N FQ R D A F LR I D M Y SM G L V L WE L V S R C K A A D G P V D E Y M LP F E E E I G Q H 
GCP    R R YM A P E V LE G A I N FQ R D A F LR I D M Y AM G L V L WE L V S R C K A A D G P V D E Y M LP F E E E I G Q H 
ZBF    R R YM A P E V LE G A I N FQ R D S F LR I D M Y AM G L V L WE L V S R C K A A D G P V D E Y M LP F E E E I G Q H 
  
RBT    P S LE D L Q D VV V H K K MR P V F K DC W L K H AG L E S M CE T I E E C W D H D A E A R L S A GC V E E R I S Q I 
ATS    P S LE D L Q D VV V H K K MR P V F K DC W L K H AG L E S M CE T I E E C W D H D A E A R L S A GC V E E R I S Q I 
GCP    P S LE D L Q D VV V H K K MR P V F K DC W L K H SG L A Q M CE T I E E C W D H D A E A R L S A GC V E E R I S Q I 
ZBF    P S LE D L Q D AV V H K K LR P A F K DC W L K H SG L C Q M CE T M E E C W D H D A E A R L S A GC V Q E R I S Q I 
  
RBT    R R LT S P P T SD C L V S MV T S V T NV D L P P KE S S I 
ATS    R R LT S P P T SD C L V S MV T S V T NV D L P P K- - - - 
GCP    R R LT S A S T SD C L L S VL T S V T NV D L P A KE S S I 
ZBF    R R VS S S - T SD C L F S MV T S L T NV D L P P KE S S I 
  
Fig.1. Rainbow trout (RBT) Acvr2b-2a deduced amino acid
sequence (ADJ19047) aligned with protein sequences from
Atlantic salmon (ATS; ABK54368), grass carp (GCP; ACI23559)
and zebrafish (ZBF; AAD19844). The extracellular and
transmembrane domains are identified with single and double
over-lines, respectively. Conserved (black), similar (gray) and
unique (white) amino acids are highlighted.
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P1 transgenic fish and all internal organs appeared normal. Enhanced
muscling did not appear to affect swimming or feeding activity.
P1 transgenic growth
There were no significant differences between the mean mass and
length of P1 transgenic and control trout when analyzed between 9
and 15months of age. Transgenic (TG) fish had significantly higher
condition factor values compared with control fish (cohort 1: TG
2.15±0.051, control 1.83±0.051; cohort 2: TG 1.93±0.045, control
1.75±0.032) throughout the study, supporting the observation that
most P1 transgenic individuals had a compact body morphology
(Fig.2A). The increased condition factor was reflective of the fact
that despite the lack of significant differences in mass and length,
transgenic fish tended to be heavier when compared with control
fish of similar length, as shown by the mass to length distribution
of both cohorts (Fig.3). At 15months of age, one transgenic fish
from cohort 2 was 65% heavier than the largest control fish (1004
versus 655g) with one of the highest condition factor values (Fig.3).
There was no significant difference in the specific growth rate
between P1 transgenics and controls.
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F1 morphology and muscle histology
F1 transgenic offspring did not possess the ‘six pack’ phenotype
observed in the P1 generation, but most individuals exhibited a
distinct compact body morphology that was readily apparent (Fig.4).
The number of muscle fibers per 0.254mm2 area of muscle tissue
A
TG
TG
C
B
Fig.2. Localized muscling exhibited by the P1 founder generation of rainbow
trout. (A)Morphology of 2-year-old acvr2b∆ transgenic (TG) and control (C)
broodstock. P1 transgenic individuals exhibit localized muscling in both the
abdominal and epaxial regions of the musculature. (B)Cross-section of a P1
transgenic fish reveals asymmetrical skeletal muscle growth.
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Fig.3. Size distribution of P1 transgenic rainbow trout at 15months of age.
Mass and length measurements are plotted for individual transgenic (TG;
black diamond) and control (gray square) fish from cohort 1 (A) and cohort
2 (B).
'
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Fig.4. Morphology of rainbow trout F1 transgenic offspring. Transgenic
(TG) F1 fish exhibited a compact body morphology compared with control
fish (C) without the presence of localized muscle growth.
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in 4-month-old transgenic individuals (122.8±5.6) was significantly
lower than in control fish (139.5±4.8; Fig.5A,D), while transgenic
muscle fiber diameter (41.05±0.84μm) was significantly larger
compared with controls (38.22±0.76μm). Despite differences in the
size of muscle fibers, the overall number of muscle fibers per cross-
sectional area did not differ between groups (TG 71,405±7010;
control 67,771±3415; Fig.5B) because of a significant increase in
the cross-sectional surface area of transgenic fish (146.1±8.1mm2)
compared with control fish (120.3±5.3mm2; Fig.5C).
F1 transgenic growth
The growth characteristics of F1 siblings from one P1 acvr2b∆ ×
acvr2b∆ cross was assessed between 5 and 10months post-hatch
[line Tg(RA.Mlc:acvr2b∆)aa26-24]. No significant difference was
observed between the mean mass of Tg(RA.Mlc:acvr2b∆)aa26-24
transgenic and control fish populations, but a distinct upper mode
of transgenic fish weighed significantly more than the average
control fish throughout the study (Fig.6A). At 10months of age,
the upper mode of Tg(RA.Mlc:acvr2b∆)aa26-24 transgenic fish was
31% heavier than controls (upper mode 621.2±58.9g, control
475.1±20.9g), with the largest transgenic weighing 55 and 13% more
than the average and largest control fish, respectively (Fig.6A). No
difference in length was detected between the upper mode of
transgenic and control fish, but the mean length of the total
transgenic population was significantly less than controls at
10months of age (Fig.6B). The Tg(RA.Mlc:acvr2b∆)aa26-24
transgenic fish had significantly higher condition factor values
throughout the study (Fig.6C).
DISCUSSION
Expression of acvr2b∆ in P1 RBT stimulated enhanced localized
muscling in the hypaxial and epaxial regions of the musculature.
This is similar to what we have observed in RBT overexpressing
follistatin (Medeiros et al., 2009), a known antagonist of several
TGF-β ligands (Welt et al., 2002; Gilson et al., 2009) that utilize
the acvr2b. This unique phenotype has now been documented in
two strains of transgenic RBT with different inhibitors of TGF-β
signaling (i.e. acvr2b∆ and follistatin), providing further evidence
that ligands of the TGF-β superfamily regulate muscle growth in
teleost fish. The phenotype is unique in that distinct localized regions
of muscle growth develop in the relatively uniform morphology of
the trout axial musculature. This may be a result of global muscle
growth without a concurrent increase in length, because transgene
expression was driven by a muscle-specific promoter. Alternatively,
the phenotype may be related to somatic mosaicism in P1 transgenic
fish, which could cause differential TGF-β inhibition in the
musculature, resulting in localized regions of muscle growth. The
lack of the ‘six pack’ phenotype in the F1 generation suggests that
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Fig.5. Mean (A) fiber number per 0.254mm2 unit area,
(B) total fiber number per cross-section and (C) cross-
sectional muscle surface area for 4-month-old transgenic
(black) and control (gray) rainbow trout. (D)Muscle
histology sections from representative control and
transgenic trout indicating muscular hypertrophy in
transgenic fish. Asterisks indicate values statistically
different from control fish.
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somatic mosaicism was likely the cause of localized muscling in
the P1 generation. Late-stage genomic integration after construct
microinjection is common in both fish and mammalian P1 transgenic
organisms, and can lead to somatic and germ tissue mosaicism
(Stuart et al., 1990; Gross et al., 1992; Whitelaw et al., 1993; Rahman
et al., 2000). Somatic mosaicism has been reported to occur in up
to 62% of transgenic mice produced by microinjection (Whitelaw
et al., 1993), with only 10–20% of the cells in a given tissue
integrating the plasmid construct (Palmiter et al., 1984).
In mammals, a number of TGF-β ligands including myostatin,
activin, GDF-11, nodal and several bone morphogenetic proteins
are known to signal through the ACVR2B (Tsuchida et al., 2008).
Activin A is suggested to work in concert with myostatin to
regulate muscle growth in mammals (Gilson et al., 2009; Lee et
al., 2010), and may have a similar role in teleost fish. However,
it remains unclear which TGF-β molecules are primarily
responsible for the enhanced muscling observed with acvr2b∆
expression in RBT.
A range of growth rates was observed in P1 acvr2b∆ transgenic
fish, with several individuals growing to substantial size, but overall
the transgenic organisms were not significantly larger than control
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fish. Size variation is common in P1 transgenic fish overexpressing
growth hormone and has been observed in P1 transgenic coho
salmon [Oncorhynchus kisutch (Walbaum 1792)], common carp
[Cyprinus carpio (Linnaeus 1758)] and northern pike [Esox lucius
(Linnaeus 1758)] (Gross et al., 1992; Devlin et al., 1995; Wang et
al., 2001). Only 8.7% of the growth hormone transgenic carp
exhibited enhanced growth, with many fish having reduced growth
(Wang et al., 2001). As a result of random genome integration,
variation in the number of integrated copies and concatemerization
of the DNA construct, each founder possesses a unique transgenic
genotype (Culp et al., 1991; Uh et al., 2006), which is reflected in
the observed morphological variation.
Although localized muscle growth was not present in the F1
generation, an overall compact body morphology developed that
was readily apparent and led to a significantly higher condition factor
in transgenic individuals. The phenotype was present in the majority
of F1 transgenic fish regardless of size, with the largest individuals
exhibiting some of the highest condition factors. Increased condition
factor was also observed in transgenic RBT overexpressing follistatin
(Medeiros et al., 2009) and in mice with the Cmpt myostatin
mutation, which develop enhanced muscling and a short, compact
body morphology (Varga et al., 1997). It is currently unclear as to
the mechanism behind the reduced length exhibited by acvr2b∆
transgenic fish. It is possible that acvr2b∆ expression may have
unknown side effects that could influence TGF-β signaling in
adjacent tissues. This may also explain the delayed maturation
observed in many P1 transgenic females. More research is needed
to fully understand the functional significance of these phenotypic
observations.
Transgenic F1 individuals at 4months post-hatch increased
muscle mass primarly through hypertrophy. This differed from
transgenic trout overexpressing follistatin, in which muscle fiber
hyperplasia was the primary mechanism for the observed increase
in muscle mass (Medeiros et al., 2009). There is currently little
consensus on the specific mechanism by which TGF-β ligands
regulate muscle growth. Myostatin-null medaka increase muscle
mass by hyperplasia, then switch to hypertrophy in adulthood
(Chisada et al., 2011). While both hypertrophy and hyperplasia of
muscle fibers have been documented with TGF-β and myostatin
inhibition in mice (Lee and McPherron, 2001), the primary
mechanism in mammals appears to be hypertrophy (Amthor et al.,
2009). Recent mammalian evidence suggests that myostatin and
activin A regulate muscle hypertrophy by directly targeting muscle
fibers with little contribution from satellite cells (Wang and
McPherron, 2012). TGF-β inhibition from follistatin and soluble
ACRV2B has been shown to increase muscle fiber hypertrophy in
mice with minimal addition of new myonuclei to existing myofibers.
These treatments also increase muscle fiber hypertrophy in mice
with inactivated satellite cells (Wang and McPherron, 2012; Lee et
al., 2012). Targeted deletion of Acrv2b in mouse muscle fibers also
induces muscle fiber hypertrophy, supporting the idea that satellite
cells are not required for hypertrophic growth (Lee et al., 2012).
Transgenic acvr2b∆ likely utilizes a similar mechanism to increase
muscle fiber hypertrophy as the truncated protein should only be
expressed in fully differentiated muscle fibers. Transgenic fish
overexpressing follistatin may exhibit a slightly different mechanism
of TGF-β inhibition because the soluble protein is not restricted to
muscle fibers. It is also possible that differences observed in acvr2b∆
and follistatin transgenic trout are related to the size or age of the
fish or to differential regulation of distinct TGF-β ligands. The
follistatin-overexpressing transgenic fish were analyzed at a mass
of ~195g and a length of 19cm (Medeiros et al., 2009), whereas
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Fig.6. Growth characteristics of rainbow trout F1 transgenic line
Tg(RA.Mlc:acvr2b∆)aa26-24. Growth pattern in (A) mass, (B) length and (C)
condition factor of the average transgenic (black circle), control (gray
square) and the upper transgenic mode (dark gray triangle) of fish between
5 and 10months of age. Asterisks indicate statistical significance of the
average transgenic fish (*) or the upper mode of transgenic fish only (**)
compared with controls.
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the F1 acvr2b∆ fish were analyzed at a significantly smaller size
(6.6±0.4g, 7.4±1.4cm).
Variation in the growth of the F1 generation limited direct
conclusions on the impact of acvr2b∆ expression on the overall
growth of transgenic trout, despite the fact that several transgenic
individuals from both F1 lines exhibited increased muscle growth.
Variation in F1 transgenic fish is not uncommon. Significant
variation has been reported in the F1 generation of transgenic
growth hormone enhanced common carp (Wang et al., 2001) and
arctic char, Salvelinus alpinus (Linnaeus 1758) (Pitkänen et al.,
2001). Similarly, two transgenic lines exhibiting dramatically
different phenotypes have also been reported from the F1
offspring of a single transgenic mouse overexpressing the
myostatin pro-peptide domain under the control of the same
RA.Mlc promoter (Lee and McPherron, 2001) used to produce
Tg(RA.Mlc:acvr2b∆) transgenics. Further variation was added to
the F1 generation of Tg(RA.Mlc:acvr2b∆)aa26-24 transgenic
trout by crossing transgenic individuals. This was done to
maximize the number of transgenic genotypes in the F1 generation
given constraints on rearing significant numbers of large
transgenic fish, which required 2years to reach maturity. Despite
the lack of conclusive growth data, the morphology exhibited by
this model organism provides compelling in vivo evidence that
ligands of the Acvr2b-2a regulate muscle growth and morphology
in teleost fish.
LIST OF ABBREVIATIONS
Acvr2b activin receptor 2B
acvr2b∆ truncated activin type IIB receptor
CDS coding sequence
F1 first generation offspring
gapdh glyceraldehyde 3-phosphate dehydrogenase
P1 founder parental generation
PIT passive integrated transponder
qRT-PCR quantitative reverse transcription PCR
RBT rainbow trout
TGF-β transforming growth factor β
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